NCBI Taxonomy: 1892
Streptomyces anulatus (ncbi_taxid: 1892)
found 114 associated metabolites at species taxonomy rank level.
Ancestor: Streptomyces anulatus subgroup
Child Taxonomies: Streptomyces chrysomallus subsp. fumigatus
Dactinomycin
A compound composed of a two cyclic peptides attached to a phenoxazine that is derived from streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DA - Actinomycines C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents
Valinomycin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D049990 - Membrane Transport Modulators D007476 - Ionophores A twelve-membered cyclodepsipeptide composed of three repeating D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl units joined in sequence. An antibiotic found in several Streptomyces strains. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic Valinomycin is a potassium-specific ionophore, the valinomycin-K+ complex can be incorporated into biological bilayer membranes with the hydrophobic surface of valinomycin, destroys the normal K+ gradient across the membrane, and as a result kills the cells, incorporating into liposomes can significantly reduces the cytotoxicity and enhances the targeting effect. Valinomycin exhibits antibiotic, antifungal, antiviral, antitumor and insecticidal efficacy, thus can be used for relevant research[1][2]. Valinomycin (NSC 122023), a cyclic depsipeptide antibiotic, act as a potassium selective ionophore. Valinomycin (NSC 122023) inhibits lymphocyte proliferation by its effects on the cell membrane, and induces apoptosis in CHO cells[1]. Valinomycin induces activation of PINK1 leading to Parkin Ser65 phosphorylation[2].
PHENAZINE
CONFIDENCE standard compound; INTERNAL_ID 191 CONFIDENCE standard compound; INTERNAL_ID 8129
phenazine-1-carboxylic acid
An aromatic carboxylic acid that is phenazine substituted at C-1 with a carboxy group. CONFIDENCE standard compound; INTERNAL_ID 190 Phenazine-1-carboxylic acid exhibits strong antifungal activity against phytopathogenic fungi.
Telomestatin
Telomestatin is a naturally occurring organic compound classified as a cyclic phenolphthioceramide derivative. It is isolated from the fermentation broth of microorganisms and is known for its antitumor properties. The name "telomestatin" reflects its primary mode of action, which is the inhibition of telomerase, an enzyme crucial for the maintenance of chromosome stability and cell proliferation, particularly in cancer cells where telomerase activity is often elevated. Telomerase is responsible for adding repetitive DNA sequences called telomeres to the ends of chromosomes, which prevents the loss of genetic material during DNA replication and cell division. By inhibiting telomerase, telomestatin interferes with the ability of cancer cells to divide and proliferate, making it a potential candidate for antitumor therapy. The compound's unique chemical structure allows it to bind specifically to the telomerase RNA component, thereby blocking the enzyme's activity. The discovery and study of telomestatin have contributed to the understanding of telomerase biology and the development of potential therapeutic strategies for cancer treatment.
actinomycin D
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents
Glucomannan
tubermycin B
Origin: Microbe; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids Phenazine-1-carboxylic acid exhibits strong antifungal activity against phytopathogenic fungi.
Cosmegen
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents
5-methyl-9-(3-methylbut-2-en-1-yl)-7-oxophenazine-1-carboxylic acid
n9-[(6s,9r,10s,13s,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-n1-[(6s,9r,10s,13s,18as)-13-[(2s)-butan-2-yl]-11-hydroxy-6-isopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid
(3s,6s)-3-methyl-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
C9H16N2O2 (184.12117160000003)
(3r,6r,9s,12s,15r,18r,21s,24s,27r,30r,33s,36s)-5,11,17,23,29,35-hexahydroxy-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriaconta-4,10,16,22,28,34-hexaene-2,8,14,20,26,32-hexone
(1s,2s,4as,5s,8r,8ar)-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydro-1h-naphthalene-1,5-diol
4-(hydroxymethyl)-7-methyl-8-[3-methyl-3-(3-methylpentyl)oxiran-2-yl]-9h-carbazole-1,6-diol
C23H29NO4 (383.20964740000005)
6-hydroxy-4-{2-[2-hydroxy-5-(hydroxymethyl)-3-methylphenyl]-2-oxoethyl}-4,5-dihydro-3h-pyridin-2-one
5-methyl-9-(3-methylbut-2-en-1-yl)-10h-phenazine-1-carboxylic acid
(2r,3r,4r,5s,6r)-2-{[(2r,3s,4r,5r,6s)-6-{[(2r,3s,4r,5r,6s)-6-{[(2r,3s,4r)-4,6-dihydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)-n,n,n-trimethyloxan-3-aminium
3-(4-chloro-1,3-oxazol-5-yl)-1h-indole
C11H7ClN2O (218.02468819999999)
(3r,6r,9s,12s,15r,18r,21s,24s,30r,33s,36s)-5,11,17,23,29,35-hexahydroxy-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriaconta-4,10,16,22,28,34-hexaene-2,8,14,20,26,32-hexone
3-methyl-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
C9H16N2O2 (184.12117160000003)
2-[(6-{[6-({4,6-dihydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl}oxy)-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)-n,n,n-trimethyloxan-3-aminium
9-(3-methylbut-2-en-1-yl)phenazine-1-carboxylic acid
C18H16N2O2 (292.12117159999997)
5,11,17,23-tetrahydroxy-3,6,9,15,18,21-hexaisopropyl-12,24-dimethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosa-4,10,16,22-tetraene-2,8,14,20-tetrone
n1,n9-bis[(6s,9r,10s,13r,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid
4-(hydroxymethyl)-7-methyl-8-[3-methyl-3-(3-methylbutyl)oxiran-2-yl]-9h-carbazole-1,6-diol
C22H27NO4 (369.19399820000007)